Intercept Pharmaceuticals, Inc. (ICPT)

Intercept Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-61.61	221.82	-91.43	-274.88	-344.68	-309.24
Depreciation & Amortization	0.38	0.59	2.81	2.94	3.66	4.58
Other Amortization	1.36	2.61	33.33	28.5	23.32	15.57
Loss (Gain) From Sale of Assets	-	-	-	-	2.68	1.33
Asset Writedown & Restructuring Costs	-	2.4	-	-	-	-
Loss (Gain) From Sale of Investments	-7.51	-0.63	4.67	4.01	-0.3	-0.03
Stock-Based Compensation	24.01	21.89	28.03	49.19	55.98	49.91
Provision & Write-off of Bad Debts	0.01	-0	0	0.05	-	-
Other Operating Activities	8.41	-304.33	-56.73	6.75	3.39	-
Change in Accounts Receivable	-6.32	1.48	-3.42	-1.79	-12.35	-9.19
Change in Inventory	1.09	0.6	0.38	0.21	-1.35	-3.63
Change in Accounts Payable	-13.15	23.29	-13.79	-4.95	56.41	10.33
Change in Unearned Revenue	-	-	-	-	-2.43	-2.02
Change in Other Net Operating Assets	-6.93	-3.45	-2.87	-8.23	-20.94	1.66
Operating Cash Flow	-63.02	-26.78	-41.07	-171.86	-236.61	-240.71
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Capital Expenditures	0.19	-0.57	-0.4	-3.89	-1.14	-0.17
Investment in Securities	167.08	-100.82	71.12	166.71	-187.85	-47.9
Other Investing Activities	-6.16	363.23	-	-	-	-
Investing Cash Flow	161.11	261.85	70.73	162.82	-188.99	-48.07

Financing Activities

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Long-Term Debt Issued	-	-	116.79	-	223.42	-
Long-Term Debt Repaid	-	-268.41	-	-	-	-
Net Debt Issued (Repaid)	-116.87	-268.41	116.79	-	223.42	-
Issuance of Common Stock	1.33	1.68	0.02	1.3	236.25	265.73
Repurchase of Common Stock	-0.43	-0.56	-77.56	-1.99	-2.16	-2.18
Other Financing Activities	-	-0.04	-38.13	-	-	-
Financing Cash Flow	-115.97	-267.32	1.12	-0.69	457.52	263.55

Net Cash Flow

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Foreign Exchange Rate Adjustments	1.36	-6.3	-2.02	0.61	-0.39	-1.53
Net Cash Flow	-16.52	-38.55	28.76	-9.13	31.53	-26.77

Free Cash Flow

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Free Cash Flow	-62.83	-27.35	-41.46	-175.76	-237.75	-240.88
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	-19.78%	-9.57%	-15.90%	-75.12%	-94.34%	-133.97%
Free Cash Flow Per Share	-1.51	-0.81	-1.30	-5.33	-7.51	-8.46
Levered Free Cash Flow	-42.4	-45.37	-49.09	-80.59	-120.24	-130.31
Unlevered Free Cash Flow	-37.36	-34.61	-48.4	-79.06	-117.84	-126.81

Additional Metrics

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash Interest Paid	9.7	23.8	18.4	19.6	-	-
Cash Income Tax Paid	5.05	5.05	-	-	-	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 20, 2025

Data Sources Report a data error